Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04754087 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial status: Recruiting to Active, Not Recruiting Site details revised at 11 of 11 sitesv10 Show 1 more changeShow less
    • Site details revised at 11 of 11 sites
  2. Minor Site details revised at 5 of 11 sitesv9
  3. Minor Site contacts updated at 5 of 11 sitesv8
  4. Minor Site details revised at 3 of 11 sitesv7
  5. Minor Site details revised at 7 of 11 sites Study title expanded, about 2 wordsv6 Show 1 more changeShow less
    • Study title expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

Show 4 earlier versionsHide 4 earlier versions
  1. Minor Site details revised at 5 of 11 sitesv5
  2. Minor Study sites: 5 to 11v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 5 · Start date changed from estimate of Sep 1, 2021 to Jul 7, 2021v3 Show 2 more changesShow less
    • Study sites: 0 to 5
    • Start date changed from estimate of Sep 1, 2021 to Jul 7, 2021
  4. Notable Start date: Jul 1, 2021 to Sep 1, 2021v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.
Trial Details
NCT Number NCT04754087
Lead Sponsor Zimmer Biomet
Conditions Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip, Osteoarthritis, Hip, Osteoarthritis of Hip, Fractures, Hip, Fracture of Hip
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov